No article text was recorded for this version.
irreversible covalent inhibition
Version 2 of 226 papers47 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Target modulation and pharmacokinetics/pharmacodynamics translation of the BTK inhibitor poseltinib for model-informed phase II dose selection
- Blog: Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
- Blog: Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
- Blog: Exploration of Piperidinols as Potential Antitubercular Agents
- Blog: Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis model
- Blog: Combined Approaches for Drug Design Points the Way to Novel Proline Racemase Inhibitor Candidates to Fight Chagas’ Disease
- Blog: Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives
- Blog: Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages
- Blog: Structure-assisted design of inhibitors targeting coronavirus main proteases
- Blog: Designed mono- and di-covalent inhibitors trap modeled functional motions for Trypanosoma cruzi proline racemase in crystallography
- Blog: A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro
- Blog: Design, synthesis, and biological evaluation of Osimertinib–Cy7 (OSA-Cy7) conjugate as potential theranostic agent targeting activating EGFR mutations
- Blog: Comparison of structures and inhibition activities of serine protease inhibitors of Trichinella spiralis and Trichinella pseudospiralis
- Blog: Integrated Mass Spectrometry Reveals Celastrol As a Novel Catechol-O-methyltransferase Inhibitor
- Blog: Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1
- Blog: CovalentInDB: a comprehensive database facilitating the discovery of covalent inhibitors
- Blog: Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
- Blog: Defining ICR-Mo, an intrinsic colistin resistance determinant from Moraxella osloensis
- Blog: 3D structures of the <i>Plasmodium vivax</i> subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitor
- Blog: Norsampsone E, an unprecedented decarbonyl polycyclic polyprenylated acylphloroglucinol with a homoadamantyl core from Hypericum sampsonii
- Blog: Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents
- Blog: Rediscovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis
- Blog: Mechanism of Action of Thalassospiramides, A New Class of Calpain Inhibitors
- Blog: GNINA 1.3: the next increment in molecular docking with deep learning
- Blog: Bulge oligonucleotide as an inhibitory agent of bacterial topoisomerase I
- Blog: Inhibition of Human Liver Cytochrome P450 by Star Fruit Juice
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_irreversible_covalent_inhibition_5078f74c,
title = {irreversible covalent inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/irreversible-covalent-inhibition/rdr_5078f74c511745e7858ce92973ac4998},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_irreversible_covalent_inhibition_5078f74c_v2,
title = {irreversible covalent inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/irreversible-covalent-inhibition/rdr_5078f74c511745e7858ce92973ac4998/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}